Nagoya City University Hospital /ID# 249094

Nagoya, Aichi-ken 467-8602

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Multiple Myeloma

Studies at this site

• A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma — Running, not enrolling